Lundbeck Q3 2019 Financial Results

9M 2019 and FY 2018 - Geographic distribution of revenue - 1 DKKm FY 2018 FY 2017 9M 2019 9M 2018 Growth Growth in local currencies % of total NORTH AMERICA: Abilify Maintena Trintellix 695 591 618 499 24% 17% 9% 1,239 974 1,103 853 29% 22% 16% Northera 1,806 1,644 1,606 1,282 25% 18% 23% Onfi 3,165 3,022 840 2,669 (69%) (70%) 12% Rexulti 1,702 1,245 1,585 1,193 33% 25% 23% Sabril 1,342 1,509 643 983 (35%) (39%) 9% Other pharmaceuticals 794 1,688 542 593 (8%) (13%) 8% Total revenue 10,743 10,673 6,937 8,072 (14%) (19%) 100% 57 Lundbeck

View entire presentation